Safety for Frequent Use Conditions of Hair Removal Device

Inclusion Criteria: * Healthy males and females, between 18 and 65 years of age. * Willing to sign informed consent. * Willing to follow the treatment schedule and post treatment follow-up. * Willingness to have photographs of the treated area taken that may be used for marketing and educational presentation and/or publications * Willingness to avoid excessive sun exposure two weeks prior treatments Exclusion Criteria: * A history of keloidal scarring (hypertrophic scars or keloids). * Active dermatologic lesion or infection in the treatment site. * Subject has permanent tattoos or makeup in the treatment area. * Recently tanned in the area to be treated and/or unable or unlikely to refrain from tanning during the study. * Subject has disease related to photosensitivity, such as porphyria, polymorphic light eruption, solar urticaria, lupus, etc * Subject has a history of herpes outbreak in the area of treatment, unless receiving preventative treatment from physician * Pregnant, planning to become pregnant, hormone fluctuations and/or breast feeding during the experiment. * Subjects with Diabetes (Type I or II) or other systemic or metabolic condition * Subject has an active electrical implant anywhere in the body, such as a pacemaker, an internal defibrillator, insulin pump, incontinence device, etc. * Subject suffers from epilepsy. * Subject has active cancer, or has a history of skin cancer or any other cancer in the area to be treated, including presence of malignant or pre-malignant pigmented lesions. * Subject received radiation therapy or chemotherapy treatments with the past 3 months. * Subject has known anticoagulative or thromboembolic condition or is on any form of anticoagulation treatment. * Subject has a history of immunosuppressant/immune deficiency disorders (including HIV infection or AIDS) or currently using immunosuppressive medications. * Subject has any other condition which in the physician's opinion would make it unsafe for the subject to be treated. * Subject had rotating type tweezer epilator treatment, or waxing within the last 3 months * Subject had electrolysis treatment within the last 6 months over the treatment area. * Subject had any type of professional intense pulsed light (IPL), laser or RF hair removal in the treatment site within the last 6 months. * Participation in a study of another device or drug within 1 month prior to enrollment or during this study. * Subject is taking medication known to induce photosensitivity, including non-steroidal anti-inflammatory agents, tetracyclines, phenothiazines, thiazide diuretics, sulfonylureas, sulfonamides, Dacarbazine (DTIC), fluorouracil, vinblastine, and griseofulvin within 4 weeks of therapy. * Subject has been taking Accutane® within 6 months of therapy. * Subject has been on steroid regimen during the last three months. * Subject is on Gold therapy (for arthritis treatment).